Literature DB >> 16869799

Cyclosporine A increases plasma concentrations and effects of repaglinide.

J T Backman, L I Kajosaari, M Niemi, P J Neuvonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16869799     DOI： 10.1111/j.1600-6143.2006.01456.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  5 in total

Review 1.  Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Cyclosporine exacerbates ketamine toxicity in zebrafish: Mechanistic studies on drug-drug interaction.

Authors:  Bonnie L Robinson; Melanie Dumas; Syed F Ali; Merle G Paule; Qiang Gu; Jyotshna Kanungo
Journal:  J Appl Toxicol       Date:  2017-06-01       Impact factor: 3.446

3.  Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Authors:  Helen E Smith; J P Jones; Thomas F Kalhorn; Federico M Farin; Patricia L Stapleton; Connie L Davis; James D Perkins; David K Blough; Mary F Hebert; Kenneth E Thummel; Rheem A Totah
Journal:  Pharmacogenet Genomics       Date:  2008-11       Impact factor: 2.089

Review 4.  Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter.

Authors:  Naina Mohamed Pakkir Maideen; Gobinath Manavalan; Kumar Balasubramanian
Journal:  Ther Adv Endocrinol Metab       Date:  2018-04-06       Impact factor: 3.565

5.  Antioxidant properties of repaglinide and its protections against cyclosporine A-induced renal tubular injury.

Authors:  Dao Li; Jin Li; Hui Li; Qiong Wu; Qi-Xiong Li
Journal:  Iran J Basic Med Sci       Date:  2016-07       Impact factor: 2.699
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.